[Septic shock in ICU: advanced therapeutics, immunoparalysis and genomics. State of the art].

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Archivos Argentinos de Pediatria

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1590/S0325-00752014000400012PMID 24955908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bleeding and coagulopathies in critical care.

  2014cited by this paper
• Coagulopathies in the PICU: DIC and liver disease.

  2013cited by this paper
• Venoarterial Extracorporeal Membrane Oxygenation Support for Refractory Cardiovascular Dysfunction During Severe Bacterial Septic Shock*

  2013cited by this paper
• Thrombomodulin in sepsis.

  2013cited by this paper
• Improved survival in venovenous vs venoarterial extracorporeal membrane oxygenation for pediatric noncardiac sepsis patients: a study of the Extracorporeal Life Support Organization registry.

  2012cited by this paper
• The pediatric sepsis biomarker risk model

  2012cited by this paper
• Clinical review: Sepsis and septic shock - the potential of gene arrays

  2012cited by this paper
• Therapeutic Apheresis in Children: Special Considerations

  2012cited by this paper
• Relationship between the timing of administration of IgM and IgA enriched immunoglobulins in patients with severe sepsis and septic shock and the outcome: a retrospective analysis.

  2012cited by this paper
• Genetics and genomics in pediatric septic shock

  2012cited by this paper
• Fluid overload is associated with impaired oxygenation and morbidity in critically ill children*

  2012cited by this paper
• Outcomes of previously healthy pediatric patients with fulminant sepsis‐induced multisystem organ failure receiving therapeutic plasma exchange

  2011cited by this paper
• Validation of a gene expression-based subclassification strategy for pediatric septic shock*

  2011cited by this paper
• Finding new therapies for sepsis: the need for patient stratification and the use of genetic biomarkers

  2011cited by this paper
• Treatment of neonatal sepsis with intravenous immune globulin.

  2011cited by this paper
• Human recombinant activated protein C for severe sepsis.

  2011cited by this paper
• Central extracorporeal membrane oxygenation for refractory pediatric septic shock

  2011cited by this paper
• Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study

  2011cited by this paper
• Sublingual microcirculatory changes during high-volume hemofiltration in hyperdynamic septic shock patients

  2010cited by this paper
• Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis.

  2010cited by this paper
• [High volume hemofiltration in septic shock].

  2010cited by this paper
• Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis

  2010cited by this paper
• Homozygosity and risk of childhood death due to invasive bacterial disease

  2009cited by this paper
• Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.

  2009cited by this paper
• &ggr;-GLOBULIN LEVELS IN PATIENTS WITH COMMUNITY-ACQUIRED SEPTIC SHOCK

  2009cited by this paper
• Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine*

  2009cited by this paper
• Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome—The ESSICS study*

  2008cited by this paper
• Role of angiotensin‐converting enzyme gene polymorphisms in children with sepsis and septic shock

  2008cited by this paper
• Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants.

  2008cited by this paper
• Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.

  2008cited by this paper
• Potential interventions in sepsis-related acute kidney injury.

  2008cited by this paper
• Multiple organ system extracorporeal support in critically ill children.

  2008cited by this paper
• Immunoparalysis and adverse outcomes from critical illness.

  2008cited by this paper
• Meta-analysis: Intravenous Immunoglobulin in Critically Ill Adult Patients with Sepsis

  2007cited by this paper
• Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: A systematic review and meta‐analysis *

  2007cited by this paper
• Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock *

  2007cited by this paper
• Score‐based immunoglobulin G therapy of patients with sepsis: The SBITS study *

  2007cited by this paper
• To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.

  2007cited by this paper
• Extracorporeal support for septic shock.

  2007cited by this paper
• The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5‐year overview 1

  2007cited by this paper
• Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial.

  2007cited by this paper
• Extracorporeal membrane oxygenation for refractory septic shock in children: One institution's experience*

  2007cited by this paper
• Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis

  2007cited by this paper
• Risk factors of acute renal failure in critically ill children: A prospective descriptive epidemiological study*

  2007cited by this paper
• High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock

  2006cited by this paper
• Pediatric hemostasis and use of plasma components.

  2006cited by this paper
• Plasma and plasma products in the treatment of massive haemorrhage.

  2006cited by this paper
• Prognosis in critically ill children requiring continuous renal replacement therapy

  2005cited by this paper
• Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children.

  2005cited by this paper
• Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients.

  2005cited by this paper
• High Volume Hemofiltration (HVHF) in Sepsis: A Comprehensive Review of Rationale, Clinical Applicability, Potential Indications and Recommendations for Future Research

  2004cited by this paper
• Fluid overload before continuous hemofiltration and survival in critically ill children: A retrospective analysis*

  2004cited by this paper
• Extracorporeal removal for sepsis: Acting at the tissue level--the beginning of a new era for this treatment modality in septic shock.

  2004cited by this paper
• Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children*

  2003cited by this paper
• Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

  2003cited by this paper
• Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis

  2003cited by this paper
• Intravenous Immunoglobulin Adjunctive Therapy in Sepsis, with Special Emphasis on Severe Invasive Group A Streptococcal Infections

  2003cited by this paper
• Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis.

  2003cited by this paper
• Renal replacement therapy for acute renal failure in children: European Guidelines

  2003cited by this paper
• Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial.

  2003cited by this paper
• Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.

  2003cited by this paper
• Low plasma granulocyte-macrophage colony stimulating factor is an indicator of poor prognosis in sepsis

  2002cited by this paper
• Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients

  2002cited by this paper
• Guidelines for assessing appropriateness of pediatric transfusion

  2002cited by this paper
• A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.

  2001cited by this paper
• 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group.

  1999cited by this paper
• A review of acute renal failure in children: incidence, etiology and outcome.

  1998cited by this paper
• Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease.

  1997cited by this paper
• Monocyte deactivation in septic patients: restoration by IFN-gamma treatment.

  1997cited by this paper
• Monocyte deactivation-rationale for a new therapeutic strategy in sepsis

  1996cited by this paper
• Plasmapheresis in severe sepsis or septic shock.

  1996cited by this paper
• Plasma exchange in patients with septic shock including acute renal failure.

  1996cited by this paper
• High-volume, Zero-balanced Hemofiltration to Reduce Delayed Inflammatory Response to Cardiopulmonary Bypass in Children

  1996cited by this paper
• Extracorporeal membrane oxygenation for refractory septic shock in children.

  1994cited by this paper
• Hemofiltration during Cardiopulmonary Bypass in Pediatric Cardiac Surgery: Effects on Hemostasis, Cytokines, and Complement Components

  1994cited by this paper
• Genetic and environmental influences on premature death in adult adoptees.

  1988cited by this paper

• Macrophages in the inflammatory response to endotoxic shock

  2024cites this paper
• LONG CHAIN POLYPHOSPHATES IDENTIFIED IN INFECTIOUS FEVER PATIENTS IN THE DEPARTMENT OF HEMATOLOGY

  2016cites this paper